Andrew Ortega-Verdaguer, Founder & CEO of IntelVasc Inc., reveals a groundbreaking subcutaneous sensor that monitors blood flow to predict vascular emergencies before they happen. Learn how this ex-surgeon-turned-entrepreneur is shifting medicine from reactive to proactive—and why AI is key to saving millions from strokes and heart disease. A must-watch for healthcare innovators!

⏱Timestamps
00:00 - Intro
00:31 - From surgeon to startup founder: Andrew’s journey
02:29 - The tragedy that sparked IntelVasc Inc.
05:51 - How the sensor works (live demo!)
09:05 - FDA timeline & 2028 market launch
14:12 - AI’s role in personalized vascular care
19:05 - Proactive medicine’s $20B opportunity
24:37 - Andrew’s AI hack for founders (Fixer.ai)
28:51 - Magic wand wish: Accelerating human trials

🩺 Learn More: Visit intelvasc.com
💼 LinkedIn: https://www.linkedin.com/in/andrewortegaverdaguer/

🔔  Enjoyed the episode? Don't forget to like, subscribe, and hit the notification bell so you never miss an update!

📌 Subscribe here: http://www.youtube.com/@FutureProofedPodcast

💬 Let me know your thoughts in the comments!

📲 Follow me on social media: www.linkedin.com/in/brentmuller

#HealthTech #AIinMedicine #StrokePrevention #HeartHealth #MedicalInnovation #FutureOfHealthcare #ProactiveMedicine #Biotech #StartupStory #FutureProofedPodcast

https://valeogrowth.com/